Insufficient scRNA-seq data for expression of SP5 at single-cell level.
Insufficient scRNA-seq data for expression of SP5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 93% | 178.83 | 229 / 245 | 88% | 16.60 | 443 / 502 |
intestine | 95% | 134.86 | 915 / 966 | 82% | 22.53 | 431 / 527 |
stomach | 87% | 203.14 | 314 / 359 | 75% | 21.10 | 215 / 286 |
liver | 92% | 101.19 | 208 / 226 | 62% | 13.67 | 251 / 406 |
uterus | 97% | 344.01 | 165 / 170 | 34% | 7.06 | 157 / 459 |
adrenal gland | 93% | 114.25 | 239 / 258 | 36% | 5.71 | 83 / 230 |
bladder | 95% | 158.33 | 20 / 21 | 30% | 7.82 | 152 / 504 |
breast | 90% | 151.91 | 415 / 459 | 25% | 3.45 | 278 / 1118 |
ovary | 52% | 36.11 | 94 / 180 | 60% | 12.74 | 260 / 430 |
lung | 74% | 54.14 | 426 / 578 | 39% | 7.08 | 449 / 1155 |
esophagus | 63% | 53.07 | 917 / 1445 | 36% | 8.60 | 66 / 183 |
skin | 72% | 235.65 | 1308 / 1809 | 12% | 1.80 | 55 / 472 |
adipose | 80% | 164.07 | 965 / 1204 | 0% | 0 | 0 / 0 |
brain | 50% | 32.46 | 1311 / 2642 | 16% | 1.14 | 110 / 705 |
pancreas | 39% | 16.27 | 129 / 328 | 26% | 2.66 | 46 / 178 |
blood vessel | 60% | 46.14 | 805 / 1335 | 0% | 0 | 0 / 0 |
kidney | 42% | 16.40 | 37 / 89 | 12% | 0.95 | 110 / 901 |
tonsil | 0% | 0 | 0 / 0 | 42% | 3.15 | 19 / 45 |
muscle | 13% | 8.81 | 108 / 803 | 0% | 0 | 0 / 0 |
thymus | 13% | 5.52 | 83 / 653 | 0% | 0.05 | 3 / 605 |
heart | 5% | 1.82 | 47 / 861 | 0% | 0 | 0 / 0 |
spleen | 0% | 0.13 | 1 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.12 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0060349 | Biological process | bone morphogenesis |
GO_0036342 | Biological process | post-anal tail morphogenesis |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0071407 | Biological process | cellular response to organic cyclic compound |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | SP5 |
Protein name | Transcription factor Sp5 |
Synonyms | |
Description | FUNCTION: Binds to GC boxes promoters elements. Probable transcriptional activator that has a role in the coordination of changes in transcription required to generate pattern in the developing embryo (By similarity). . |
Accessions | ENST00000375281.4 Q6BEB4 |